Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patients
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to EGFR-mutated NSCLC
Related studies linked through entity extraction aliases.
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC
- Status
- RECRUITING
- Phase
- PHASE1
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
- Status
- TERMINATED
- Phase
- PHASE1